| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
1,153 |
1,052 |
$1.31M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,727 |
5,423 |
$839K |
| J0178 |
Injection, aflibercept, 1 mg |
949 |
927 |
$612K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,549 |
7,164 |
$284K |
| 92134 |
|
11,069 |
10,215 |
$172K |
| J7999 |
Compounded drug, not otherwise classified |
1,250 |
1,194 |
$29K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
296 |
288 |
$21K |
| J9035 |
Injection, bevacizumab, 10 mg |
112 |
103 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
111 |
107 |
$7K |
| 92235 |
|
160 |
121 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
120 |
117 |
$3K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
45 |
45 |
$1K |
| 92226 |
|
294 |
173 |
$1K |
| 92202 |
|
220 |
213 |
$319.33 |
| 92225 |
|
26 |
14 |
$76.51 |
| 92250 |
|
16 |
16 |
$59.26 |